• Home
  • Search
  • Hierarchical Negative Sampling Based Graph Contrastive Learning Approach for Drug-Disease Association Prediction.
  • Cite Icon9
  • https://doi.org/10.1109/jbhi.2024.3360437Copy DOI Icon

Hierarchical Negative Sampling Based Graph Contrastive Learning Approach for Drug-Disease Association Prediction.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Predicting potential drug-disease associations (RDAs) plays a pivotal role in elucidating therapeutic strategies for diseases and facilitating drug repositioning, making it of paramount importance. However, existing methods are constrained and rely heavily on limited domain-specific knowledge, impeding their ability to effectively predict candidate associations between drugs and diseases. Moreover, the simplistic definition of unknown information pertaining to drug-disease relationships as negative samples presents inherent limitations. To overcome these challenges, we introduce a novel hierarchical negative sampling-based graph contrastive model, termed HSGCLRDA, which aims to forecast latent associations between drugs and diseases. In this study, HSGCLRDA integrates the association information as well as similarity between drugs, diseases and proteins. Meanwhile, the model constructs a drug-disease-protein heterogeneous network. Subsequently, employing a hierarchical structural sampling technique, we establish reliable negative drug-disease samples utilizing PageRank algorithms. Utilizing meta-path aggregation within the heterogeneous network, we derive low-dimensional representations for drugs and diseases, thereby constructing global and local feature graphs that capture their interactions comprehensively. To obtain representation information, we adopt a self-supervised graph contrastive approach that leverages graph convolutional networks (GCNs) and second-order GCNs to extract feature graph information. Furthermore, we integrate a contrastive cost function derived from the cross-entropy cost function, facilitating holistic model optimization. Experimental results obtained from benchmark datasets not only showcase the superior performance of HSGCLRDA compared to various baseline methods in predicting RDAs but also emphasize its practical utility in identifying novel potential diseases associated with existing drugs through meticulous case studies.

Similar Papers
  • PDF
  • Research Article
  • Citations4

Predicting potential miRNA-disease associations based on more reliable negative sample selection

  • Oct 17, 2022
  • BMC Bioinformatics
  • Ruiyu Guo +4
  • Research Article

A Hierarchical Attention-Based Negative Sampling Method for Drug Repositioning Using Neighborhood Interaction Fusion.

  • Feb 01, 2026
  • IEEE journal of biomedical and health informatics
  • Chenglong Mi +5
  • Research Article
  • Citations18

Link Prediction Only With Interaction Data and its Application on Drug Repositioning.

  • Apr 24, 2020
  • IEEE Transactions on NanoBioscience
  • Juan Liu +2
  • Research Article
  • Citations6

SMDPG: Identifying Metabolite-Disease Associations via Optimized Negative Sampling and Sparse Graph Convolutional Network.

  • Mar 01, 2025
  • IEEE transactions on computational biology and bioinformatics
  • Yiran Huang +4
  • Conference Article
  • Citations1

Prediction of miRNA and Disease Association based on Graph Convolution Network using Latent Feature Vector by Positive Samples

  • Dec 06, 2022
  • Jiancheng Zhong +4
  • Research Article
  • Citations32

MGCNSS: miRNA-disease association prediction with multi-layer graph convolution and distance-based negative sample selection strategy.

  • Mar 27, 2024
  • Briefings in bioinformatics
  • Zhen Tian +4
  • Conference Article
  • Citations8

Predicting Drug-Disease Treatment Associations Based on Topological Similarity and Singular Value Decomposition

  • Nov 01, 2019
  • Guangsheng Wu +1
  • Research Article
  • Citations361

Improving compound-protein interaction prediction by building up highly credible negative samples.

  • Jun 10, 2015
  • Bioinformatics
  • Hui Liu +4
  • Research Article

Drug repositioning with metapath guidance and adaptive negative sampling enhancement.

  • Nov 01, 2025
  • Journal of biomedical informatics
  • Yaozheng Zhou +5
  • Research Article

Dual-track collaboration: Joint processing of heterogeneous positive and negative graph convolutional network for whole-slide image analysis.

  • Oct 01, 2025
  • Computer methods and programs in biomedicine
  • Meiyan Liang +7
  • Research Article
  • Citations2

DAHNGC: A Graph Convolution Model for Drug-Disease Association Prediction by Using Heterogeneous Network.

  • Sep 01, 2023
  • Journal of Computational Biology
  • Jiancheng Zhong +4
  • Research Article
  • Citations4

SURE: Screening unlabeled samples for reliable negative samples based on reinforcement learning

  • Feb 03, 2023
  • Information Sciences
  • Ying Li +7
  • PDF
  • Research Article
  • Citations50

Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition

  • Mar 01, 2019
  • BMC Bioinformatics
  • Guangsheng Wu +2
  • Research Article
  • Citations25

RLFDDA: a meta-path based graph representation learning model for drug–disease association prediction

  • Dec 01, 2022
  • BMC bioinformatics
  • Meng-Long Zhang +5
  • Research Article
  • Citations399

Predicting drug-disease associations through layer attention graph convolutional network.

  • Oct 20, 2020
  • Briefings in Bioinformatics
  • Zhouxin Yu +4
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.